Moon‐Kyu Lee

1.1k total citations
29 papers, 883 citations indexed

About

Moon‐Kyu Lee is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Moon‐Kyu Lee has authored 29 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Moon‐Kyu Lee's work include Diabetes Treatment and Management (13 papers), Diabetes Management and Research (10 papers) and Metabolism, Diabetes, and Cancer (10 papers). Moon‐Kyu Lee is often cited by papers focused on Diabetes Treatment and Management (13 papers), Diabetes Management and Research (10 papers) and Metabolism, Diabetes, and Cancer (10 papers). Moon‐Kyu Lee collaborates with scholars based in South Korea, Thailand and India. Moon‐Kyu Lee's co-authors include Kwang‐Won Kim, Myung‐Shik Lee, Jae Hoon Chung, Dong‐Jun Kim, Yong‐Ki Min, Jung Hyun Yang, Jong Ryeal Hahm, Jung‐Hyun Yang, Seok Jin Nam and Mi‐Hyun Kim and has published in prestigious journals such as PLoS ONE, Diabetes and Endocrinology.

In The Last Decade

Moon‐Kyu Lee

29 papers receiving 847 citations

Peers

Countries citing papers authored by Moon‐Kyu Lee

Since Specialization

Citations

This map shows the geographic impact of Moon‐Kyu Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moon‐Kyu Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moon‐Kyu Lee more than expected).

Fields of papers citing papers by Moon‐Kyu Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moon‐Kyu Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moon‐Kyu Lee. The network helps show where Moon‐Kyu Lee may publish in the future.

Co-authorship network of co-authors of Moon‐Kyu Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Moon‐Kyu Lee. A scholar is included among the top collaborators of Moon‐Kyu Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moon‐Kyu Lee. Moon‐Kyu Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives 2020 ·Diabetes Therapy ·Kamlesh Khunti, Mohamed Hassanein, Moon‐Kyu Lee, Viswanathan Mohan, Aslam Amod	22
2	Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study) 2020 ·Diabetes Obesity and Metabolism ·Gyuri Kim, Soo Lim, Hyuk‐Sang Kwon, Ie Byung Park, Kyu Jeung Ahn, Cheol‐Young Park, Su Kyoung Kwon, (unknown), (unknown), Sin Gon Kim, Min Kyong Moon, Eun S. Kim, Choon Hee Chung, Kang Seo Park, Mi-Kyung Kim, Dong Jin Chung, (unknown), Tae Hyong Kim, Moon‐Kyu Lee	13
3	Efficacy and safety of gemigliptin as add‐on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study) 2019 ·Diabetes Obesity and Metabolism ·Young Min Cho, Chaicharn Deerochanawong, (unknown), Swangjit Suraamornkul, (unknown), (unknown), Parinya Chamnan, (unknown), Natapong Kosachunhanun, Thongchai Pratipanawatr, Sompongse Suwanwalaikorn, Woo Je Lee, Sungrae Kim, (unknown), Eun Seok Kang, (unknown), Sam Hyun Kwon, Moon‐Kyu Lee	6
4	Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double‐blind, non‐inferiority trial 2018 ·Diabetes Obesity and Metabolism ·Yonghyun Kim, Eun Seok Kang, Hak Chul Jang, Dong Jun Kim, (unknown), Eun Sook Kim, Nan Hee Kim, Kyung Mook Choi, Sungrae Kim, Ji Young You, (unknown), Moon‐Kyu Lee	9
5	The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus 2017 ·Expert Opinion on Pharmacotherapy ·Gyuri Kim, Se Won Oh, Sang‐Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon‐Kyu Lee	27
6	Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study 2015 ·European Journal of Endocrinology ·Sebastian JCMM Neggers, Vyacheslav Pronin, Inga Balcere, Moon‐Kyu Lee, Liudmila Rozhinskaya, Marcello D. Bronstein, Mônica R. Gadelha, Pascal Maisonobe, Caroline Sert, Aart Jan van der Lely, (unknown)	32
7	Efficacy and safety of lanreotide autogel (LAN-ATG) 120 mg at extended dosing intervals (EDIs) in acromegalic patients biochemically controlled with octreotide LAR (OCT-LAR) 10 or 20 mg: The LEAD study 2014 ·Endocrine Abstracts ·(unknown), Vyacheslav Pronin, Inga Balcere, Moon‐Kyu Lee, Liudmila Rozhinskaya, Marcello D. Bronstein, Mônica R. Gadelha, Pascal Maisonobe, Caroline Sert	1
8	Effectiveness of 3-Day Continuous Glucose Monitoring for Improving Glucose Control in Type 2 Diabetic Patients in Clinical Practice 2014 ·Diabetes & Metabolism Journal ·So Yoon Kim, Hye Jeong Kim, Tae‐Hun Kim, Kyu Yeon Hur, Sun Wook Kim, Moon‐Kyu Lee, Yong‐Ki Min, Kwang‐Won Kim, Jae Hoon Chung, Jae Hyeon Kim	19
9	Insulin Receptor-Overexpressing β-Cells Ameliorate Hyperglycemia in Diabetic Rats through Wnt Signaling Activation 2013 ·PLoS ONE ·Mi‐Hyun Kim, (unknown), Moon‐Kyu Lee	14
10	Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: An Asian-Pacific perspective and expert recommendations 2011 ·Diabetes Research and Clinical Practice ·Wayne Huey‐Herng Sheu, Azhari Rosman, Ambrish Mithal, Namsik Chung, Yean Teng Lim, Chaicharn Deerochanawong, Pradana Soewondo, Moon‐Kyu Lee, Kun‐Ho Yoon, Oliver Schnell	31
11	Effects of Acupuncture at GB30, GB34, and BL40 on Functional Recovery after Sciatic Crushed Nerve Injury in Rats 2010 ·Moon‐Kyu Lee, Yun-Kyung Song, (unknown)	1
12	USF Inhibits Cell Proliferation through Delay in G2/M Phase in FRTL-5 Cells 2007 ·Endocrine Journal ·Hye Seung Jung, (unknown), Yun Jae Chung, (unknown), Yong‐Ki Min, Myung‐Shik Lee, Moon‐Kyu Lee, Kwang‐Won Kim, Jae Hoon Chung	17
13	A Patient with Primary Squamous Cell Carcinoma of the Thyroid Intermingled with Follicular Thyroid Carcinoma that Remains Alive more than 8 Years after Diagnosis 2006 ·The Korean Journal of Internal Medicine ·Tae Sik Jung, Young Lyun Oh, Young‐Ki Min, Myung‐Shik Lee, Moon‐Kyu Lee, Kwang‐Won Kim, Jae Hoon Chung	7
14	Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects 2005 ·Diabetes Research and Clinical Practice ·(unknown), Dong Joon Kim, Myung‐Shik Lee, Kwang‐Won Kim, Moon‐Kyu Lee	10
15	Fasting Plasma Glucose Cutoff Value for the Prediction of Future Diabetes Development: A Study of Middle-Aged Koreans in a Health Promotion Center 2005 ·Journal of Korean Medical Science ·Dong‐Jun Kim, (unknown), Jung Hyun Noh, Hyun‐Jin Kim, Yoon‐Ho Choi, Jaehoon Jung, Yong‐Ki Min, Myung‐Shik Lee, Moon‐Kyu Lee, Kwang‐Won Kim	10
16	Prevalence, Clinical and Ultrasonographic Characteristics of Thyroid Incidentalomas 2004 ·Thyroid ·(unknown), (unknown), Jae Hoon Chung, (unknown), Myung‐Shik Lee, Moon‐Kyu Lee, Jung Hyun Yang, Kwang‐Won Kim	159
17	Significance of [beta ]2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects 2002 ·Metabolism ·Sung‐Hoon Kim, Dong‐Jun Kim, (unknown), Yong‐Ki Min, Myung‐Shik Lee, Kwang‐Won Kim, Moon‐Kyu Lee	35
18	Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus 2001 ·Metabolism ·Dong‐Jun Kim, (unknown), Kwang‐Won Kim, Moon‐Kyu Lee	123
19	Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid Diseases 2001 ·Thyroid ·Jong Ryeal Hahm, Myung‐Shik Lee, Yong‐Ki Min, Moon‐Kyu Lee, Kwang‐Won Kim, Seok Jin Nam, Jung‐Hyun Yang, Jae Hoon Chung	135
20	Fas is Expressed in Murine Pancreatic Islet Cells and an Insulinoma Cell Line but Does Not Mediate Their Apoptosis in vitro 1999 ·Autoimmunity ·(unknown), (unknown), (unknown), Jae Hoon Chung, Moon‐Kyu Lee, Kwang-Won Kim	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact